Skip to content

High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis

High Flow Oxygen Therapy vs Standard Care in Infants With Viral Bronchiolitis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03252119
Enrollment
28
Registered
2017-08-17
Start date
2017-06-01
Completion date
2018-08-31
Last updated
2019-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis, Viral

Brief summary

A randomized control trial of 130 infants admitted to the paediatric high care admission ward will be enrolled, and randomized to either high flow humidified oxygen or standard therapy.

Detailed description

A randomized control trial of 130 infants admitted to the paediatric high care admission ward will be enrolled. Infants between 1 month and 2 years of age who fulfill criteria for enrollment shall be considered eligible. Informed consent from parents or legal guardians shall be obtained. Infants shall be randomized to either standard therapy or high flow humidified oxygen. Measurements of heart rate, respiratory rate, work of breathing (Tal score and WCAS), oxygen saturation and oxygen requirements shall be recorded.

Interventions

DEVICEHigh flow humidified oxygen therapy

application of high flow humidified oxygen therapy at 2l/kg/min

Sponsors

Chris Hani Baragwanath Academic Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to 2 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of viral bronchiolitis * Not requiring intubation and ventilation * Admitted to high care unit * With moderate/severe respiratory distress (Tal score \>6) * Saturations \<92% in room air

Exclusion criteria

* congenital cardiac disease * presence of multiorgan failure/multisystemic disease * previously ventilated * craniofacial abnormalities * nasal pathology * decreased level of consciousness * Ex-prem \<34 weeks * Possible impending respiratory failure

Design outcomes

Primary

MeasureTime frameDescription
Effect of high flow humidified oxygen therapy on work of breathingduring first 5 days post enrollmentRespiratory rate (n/min)
Effect of high flow humidified oxygen therapy on blood oxygen saturationsfirst 5 days post enrollmentSaturation of oxygen (% saturation) as measured by pulse oximeter
Effect of high flow humidified oxygen therapy on heart ratefirst 5 days post enrollmentPulse (n/min) measured by ECG monitor

Secondary

MeasureTime frameDescription
Proportion of patients requiring intubation and ventilationfrom time of enrollment to end of hospital stay (up to 6 months)number of patients (N) getting intubated
Length of hospital stayfrom time of enrollment to end of hospital stay (up to 6 months)days (N) spent in hospital

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026